Press enter to begin your search

Open Orphan - Confirmation of Hvivo acquisition

ORPH
Fri, 10 Jan 2020, 14:30 GMT

Cathal Friel, Chief Executive of Open Orphan, discusses the Hvivo acquisition and the management team of the group going into 2020.

Cathal Friel
CEO
ORPH
5e16fc80fb21a407ce74bd45
SHOW MORE
FROM THIS COMPANY
Open Orphan - Confirmation of Hvivo acquisition
ORPH Fri, 10 Jan 2020, 14:30 GMT

Open Orphan was founded in 2017, with the goal of becoming Europe’s leading rare disease and orphan drug-focused pharma services company by a management team with extensive industry and financial expertise.

Industry: Health Care

Contact: +353 (01) 6440007
Dublin 2, Ireland
https://www.openorphan.com

Cathal Friel, Chief Executive of Open Orphan, discusses the Hvivo acquisition and the management team of the group going into 2020.

Cathal Friel
CEO
POWERED BY